53 related articles for article (PubMed ID: 3694788)
1. [Evaluation of oral amphotericin B with serial measurement of the serum concentration in patients with leukemia and related disorders].
Okuda T; Nishigaki H; Yokota S; Horiike S; Yashige H; Nishida K; Maekawa T; Tsuda S; Taniwaki M; Sonoda Y
Jpn J Antibiot; 1987 Sep; 40(9):1644-50. PubMed ID: 3694788
[TBL] [Abstract][Full Text] [Related]
2. Prophylactic and therapeutic effects of oral administration of amphotericin B in mycosis associated with hematologic diseases. Study Group of Mycosis in Hematologic Disease.
Urabe A; Takaku F; Mizoguchi H; Nomura T; Ogawa T; Maekawa T; Omine M; Miura Y; Hirashima K; Takatani O
Jpn J Antibiot; 1990 Jan; 43(1):116-30. PubMed ID: 2190013
[TBL] [Abstract][Full Text] [Related]
3. [Mycotic liver and spleen abscesses successfully treated by intraportal and intrahepatosplenic arterial administration of antimycotic drugs in two cases with acute leukemia].
Chujo T; Kuratsune H; Nishimori Y; Machii T; Kitani T; Kimoto Y; Hashimoto T; Nakamura H; Aozasa K
Rinsho Ketsueki; 1989 May; 30(5):736-45. PubMed ID: 2677438
[TBL] [Abstract][Full Text] [Related]
4. Tolerance of high doses of amphotericin B by infusion of a liposomal formulation in children with cancer.
Emminger W; Graninger W; Emminger-Schmidmeier W; Zoubek A; Pillwein K; Susani M; Wasserer A; Gadner H
Ann Hematol; 1994 Jan; 68(1):27-31. PubMed ID: 8110875
[TBL] [Abstract][Full Text] [Related]
5. [Comparison of oral fluconazole and amphotericin B prophylaxis against fungal infections in the neutropenic phase of patients treated with antileukemic agents].
Finke R
Mycoses; 1990; 33 Suppl 1():42-54. PubMed ID: 2101864
[TBL] [Abstract][Full Text] [Related]
6. [The effect of oral high-dose amphotericin B in patients with acute leukemia: detection of fungi and prophylaxis for fungal infection].
Motomura S; Noguchi T; Kanamori H; Murata T; Harano H; Takahashi K; Matsuzaki M; Miyashita H; Ogawa K; Ito A
Rinsho Ketsueki; 1987 Nov; 28(11):1956-62. PubMed ID: 3446867
[No Abstract] [Full Text] [Related]
7. Prevention of bacterial and fungal infections in acute leukemia patients: a new and potent combination of oral norfloxacin and amphotericin B.
Yamada T; Dan K; Nomura T
Intern Med; 1993 Sep; 32(9):710-5. PubMed ID: 8142675
[TBL] [Abstract][Full Text] [Related]
8. [A co-operative study on prophylaxis of fungal infection in patients with hematological diseases: prophylactic effect of oral administration of amphotericin B (author's transl)].
Suda T; Omine M; Tsuchiya J; Maekawa T; Muto Y; Mizoguchi H; Sakamoto S; Takaku F; Enokihara H; Saito K; Hirose K; Furusawa S; Shishido H
Rinsho Ketsueki; 1980 Feb; 21(2):195-9. PubMed ID: 7411865
[No Abstract] [Full Text] [Related]
9. A randomized, double-blind comparative trial evaluating the safety of liposomal amphotericin B versus amphotericin B lipid complex in the empirical treatment of febrile neutropenia. L Amph/ABLC Collaborative Study Group.
Wingard JR; White MH; Anaissie E; Raffalli J; Goodman J; Arrieta A;
Clin Infect Dis; 2000 Nov; 31(5):1155-63. PubMed ID: 11073745
[TBL] [Abstract][Full Text] [Related]
10. [Amphotericin B level in feces and serum during oral administration in newborns at risk].
Blaschke-Hellmessen R; Schwarze R
Mycoses; 1994; 37 Suppl 1():84-8. PubMed ID: 7854372
[TBL] [Abstract][Full Text] [Related]
11. Comparison of posaconazole versus weekly amphotericin B lipid complex for the prevention of invasive fungal infections in hematopoietic stem-cell transplantation.
Chaftari AM; Hachem RY; Ramos E; Kassis C; Campo M; Jiang Y; Prince RA; Wang W; Raad II
Transplantation; 2012 Aug; 94(3):302-8. PubMed ID: 22814329
[TBL] [Abstract][Full Text] [Related]
12. Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group.
Walsh TJ; Finberg RW; Arndt C; Hiemenz J; Schwartz C; Bodensteiner D; Pappas P; Seibel N; Greenberg RN; Dummer S; Schuster M; Holcenberg JS
N Engl J Med; 1999 Mar; 340(10):764-71. PubMed ID: 10072411
[TBL] [Abstract][Full Text] [Related]
13. [A co-operative study on prophylactic effect of oral administration of high-dose amphotericin B syrup for systemic fungal infection in patients with hematological neoplasms. Chugoku-Shikoku Study Group of Mycosis with Hematologic Disease].
Kimura I; Kuramoto J; Yahata Y; Irino S; Takahashi I; Sezaki T; Tsubota T; Watanabe Y; Hara M; Hino N
Gan To Kagaku Ryoho; 1990 May; 17(5):1027-32. PubMed ID: 2185693
[TBL] [Abstract][Full Text] [Related]
14. [Differentiation of intestinal candidial colonization from invasive candidiasis by measuring serum level of D-arabinitol in combination with oral administration of low dose amphotericin B].
Fujita N; Hamada K; Takahashi H; Yoshimura M; Nakanishi S; Gotoh H; Oku N; Inaba T; Muragashira S; Ito K
Rinsho Byori; 1991 Aug; 39(8):895-7. PubMed ID: 1920890
[TBL] [Abstract][Full Text] [Related]
15. [Multiple liver abscesses due to Candida albicans in a patient with acute promyelocytic leukemia: percutaneous transhepatic intraportal administration of amphotericin B].
Ishii H; Hiruma K; Morio S; Hirasawa A; Wakita H; Endoh N; Oh H; Yoshida S; Aotsuka N; Asai T
Rinsho Ketsueki; 1990 Mar; 31(3):330-4. PubMed ID: 2366337
[TBL] [Abstract][Full Text] [Related]
16. Discontinuation of oral amphotericin B therapy does not influence the pharmacokinetics of tacrolimus in heart transplant patients.
Ikura M; Nakamura T; Uno T; Nakagita K; Takenaka H; Matsuda S; Oda R; Wada K; Hattori Y; Seguchi O; Yanase M; Hayakawa N; Fukushima N
Int J Clin Pharmacol Ther; 2021 Aug; 59(8):566-571. PubMed ID: 34085636
[TBL] [Abstract][Full Text] [Related]
17. [Clinical study of the prevention of deep fungal infection by oral administration of large dose of amphotericin-B].
Shibuya T; Morioka E; Ohhara N; Niho Y
Kansenshogaku Zasshi; 1987 Mar; 61(3):287-91. PubMed ID: 3112281
[No Abstract] [Full Text] [Related]
18. Failure of fluconazole prophylaxis to reduce mortality or the requirement of systemic amphotericin B therapy during treatment for refractory acute myeloid leukemia: results of a prospective randomized phase III study. German AML Cooperative Group.
Kern W; Behre G; Rudolf T; Kerkhoff A; Grote-Metke A; Eimermacher H; Kubica U; Wörmann B; Büchner T; Hiddemann W
Cancer; 1998 Jul; 83(2):291-301. PubMed ID: 9669812
[TBL] [Abstract][Full Text] [Related]
19. [In vitro susceptibility to fluconazole of fungal strains freshly isolated from child patients with deep-seated mycoses].
Yamaguchi H; Uchida K
Jpn J Antibiot; 1993 Aug; 46(8):647-53. PubMed ID: 8230734
[TBL] [Abstract][Full Text] [Related]
20. [Safety of long-term administration of conventional amphotericin B in oncology patients].
Doubek M; Mayer J; Horký D
Cas Lek Cesk; 2002 Mar; 141(5):156-9. PubMed ID: 11998223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
